Free tool
FAERS Monitor: Zinc Sulfate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209377 or its brand name (Zinc Sulfate, Zinc Sulfate). Reports on generic versions are filed under their own applications.
Reports
2,864
Serious
2,169
76% of reports
Hospitalization
1,285
Death reported
396
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea226
- fatigue185
- nausea177
- off label use158
- death156
- pain147
- vomiting145
- dyspnoea140
- pyrexia131
- headache111
- asthenia103
- pneumonia101
- back pain96
- anaemia95
- drug ineffective94
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 48 |
| 2005 | 20 |
| 2006 | 25 |
| 2007 | 26 |
| 2008 | 21 |
| 2009 | 45 |
| 2010 | 44 |
| 2011 | 48 |
| 2012 | 225 |
| 2013 | 44 |
| 2014 | 63 |
| 2015 | 92 |
| 2016 | 156 |
| 2017 | 114 |
| 2018 | 152 |
| 2019 | 158 |
| 2020 | 373 |
| 2021 | 231 |
| 2022 | 262 |
| 2023 | 193 |
| 2024 | 163 |
| 2025 | 210 |
| 2026 | 151 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,295 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anaemiaSignal | 95 | 3.7 | 3.0 | 183 |
| back painSignal | 96 | 3.0 | 2.5 | 130 |
| pyrexiaSignal | 131 | 2.8 | 2.4 | 150 |
| diarrhoeaSignal | 226 | 2.6 | 2.3 | 222 |
| pneumoniaSignal | 101 | 2.3 | 1.9 | 73 |
| vomitingSignal | 145 | 2.3 | 1.9 | 103 |
| astheniaSignal | 103 | 2.0 | 1.7 | 52 |
| dyspnoea | 140 | 1.8 | 1.5 | 52 |
| pain | 147 | 1.8 | 1.5 | 49 |
| fatigue | 185 | 1.7 | 1.5 | 60 |
| nausea | 177 | 1.6 | 1.4 | 46 |
| death | 156 | 1.3 | 1.1 | 13 |
| off label use | 158 | 1.3 | 1.1 | 13 |
| headache | 111 | 1.3 | 1.1 | 8 |
| drug ineffective | 94 | 0.5 | 0.4 | 43 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.